Celebrating Health Innovation at SXSW Online 2021

COVID-19: The New Reality with Dr. Michael Osterholm and Real Chemistry Advisor, Jane Sarasohn-Kahn

We are proud to have earned a featured session with Dr. Osterholm and our advisor and health economist Jane Sarasohn-Kahn, to speak to the SXSW community about what is next in the fight against COVID-19. From the immediate concerns around new variants to the “collateral damage” we face from this pandemic, Dr. Osterholm and Ms. Sarasohn-Kahn will share insights to help navigate public health in 2021 and beyond.

• Dr. Michael Osterholm, Director, CIDRAP, University of Minnesota
• Jane Sarasohn-Kahn, Health Economist, Advisor, Real Chemistry

Tech-Enabled Health Solutions and Patient Outcomes

In the year since the COVID-19 global pandemic changed life as we know it, virtually every sector of the economy has adjusted to a new reality of customers stuck at home, unable to travel but still needing services. Healthcare professionals did what other customer-focused sectors were doing: they turned to technology.

Tech-enabled health solutions, such as robotics, wearables, and mobile applications, have been fueled by this increased level of consumer comfort using technology to address their healthcare needs. This panel explores examples of how patient lives have improved as a direct result of breakthrough elements of health technology. The panelists will also discuss challenges that have come from this new ecosystem.

• Terri Sanders, Senior Vice President, Enterprise Marketing and Communications, HIMSS
• Ivan Tornos, Group President, Global Businesses and the Americas, Zimmer Biomet
• David Cassak, Co-Editor-in-Chief and Managing Partner, MedTech Strategist

@Doctor @Patient: Healthcare Trends on Twitter

On March 11, 2020, the World Health Organization declared COVID-19 a pandemic, ushering in the most profound change in medical care in the modern era. In-person interaction with the medical system—outside of treatment for SARS-CoV2 infection— disappeared nearly overnight, fundamentally altering physicians' relationships with their patients, and their peers. Twitter sits at the intersection of relevant conversation from patients, caretakers, HCPs, and public health officials. At Real Chemistry, we observed a 93% increase in patient engagement with physician content on the platform from March through August of 2020. Using Symplur, an analytics platform purpose-built for healthcare, we explored how connections between physicians, their patients and their peers on Twitter impacted the delivery of healthcare and medical information. This panel will share those findings and explore future social media trends in the healthcare industry.

• Lisa Bookwalter, Director, Twitter Client Solutions, Health
• Austin Lee Chiang, MD, MPH, Chief Medical Social Media Officer, Jefferson Health
• Seth Duncan, Chief Data Officer, Real Chemistry

Patient-Centricity Reduces Healthcare Inequality

The CDC has reported increasing evidence that some racial and ethnic minority groups are being disproportionately affected by COVID-19. Factors such as poverty, lack of access to healthcare and poor housing conditions contributed to this inequity. Patient-centric solutions in healthcare have the power to help reduce this inequality. Looking holistically at a patient's journey requires navigating the impacts of race, gender, ethnicity and religion. This deep understanding of the patient experience supports development of innovative solutions and behavioral drivers of care. This panel will explore the importance of involving diverse patient voices in conversations around clinical trials, drug development, and advances in specific disease areas.

• Mary Stutts, Senior Vice President, Corporate Relations, Sumitovant Biopharma
• Mary Michael, Vice President, Patient Advocacy and Stakeholder Management, Otsuka
• Anya Harry, MD, PhD, Global Head, Demographics and Diversity, GlaxoSmithKline
• Abby Hayes, Practice Leader, DEI Engagement, Real Chemistry